Introduction
Human papillomaviruses (HPV) of high risk type, such as HPV16, can directly transform mucosal epithelia and are considered important etiologic agents of cervical, anal and oropharyngeal cancers. More than 99% of cervical cancers contain HPV genomes and express HPV transcripts (Walboomers et al., 1999) . In these lesions, and in cell lines established there from, HPV transcripts are initiated at the viral regulatory region and contain the E6 and E7 open reading frames (ORFs) (Schwarz et al., 1986 (Schwarz et al., , 1985 Seedorf et al., 1987) . Indeed, viral E6 and E7 oncogenic proteins are predominantly responsible for degradation of the cell cycle regulatory factors p53, TAp63 and pocket proteins, amongst other processes contributing to carcinogenic transformation (Ben Khalifa et al., 2011) (reviewed in (Munger and Howley, 2002; McLaughlin-Drubin and Munger, 2009; Howie et al., 2009) ). In addition, continuous expression of E6 and E7 is necessary for maintenance of the transformed phenotype in cell culture. In patients, the carcinogenic progression induced by HPV is a multistep process, starting with infection of the keratinocytes forming the basal layer of the epithelium, followed by the development of low and high grade precancerous lesions (Cervical Intraepithelial Neoplasia or CIN), and eventually fully-fledged carcinoma of either Squamous Cell Carcinoma (SCC) or adenocarcinoma (ADC) types. Carcinogenic progression requires persistent HPV infection and is thought to be associated with major rearrangements in the HPV transcriptome, leading eventually to sole expression of E6 and E7. However, little is known about the nature of these rearrangements. To date, viral transcription within the high risk genotypes HPV16, 18 and 31 has most commonly been studied in vitro in cell lines or keratinocytes differentiated in 3D raft cultures (Schwarz et al., 1985; Milligan et al., 2007; Baker et al., 1987; Zheng and Baker, 2006; Smotkin and Wettstein, 1986; Gray et al., 2010; Wang et al., 2011; Schmitt et al., 2011) . A small number of cell lines have also been derived from lower grade lesions containing nonintegrated episomal high risk HPV genomes or from benign condylomas associated with low risk HPV types genomes (Milligan et al., 2007; Bedell et al., 1991) ; HPV16 transcripts have been mapped in one such line (Milligan et al., 2007; Doorbar et al., 1990) but the extent to which these data reflect the in vivo situation remains unclear. Moreover, these studies cannot address the important question of how the transcript map might evolve during carcinogenic progression, and so any association between Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/yviro changes in HPV transcription and in vivo oncogenesis remains undefined. Recent data from our lab suggest that loss of E2 protein expression, which is common in cervical cancer (Xue et al., 2010) , is unexpectedly independent of the disruption of the E2 gene that occurs during integration of the viral genome in $ 40% of HPV16-associated cancers (Xue et al., 2012; Das Ghosh et al., 2012) . To understand this, better knowledge of the structure of viral transcripts is needed, and of their temporal regulation during cancer progression, in particular regarding expression of E1\widehatE4 and E2 transcripts relative to that of E6 and E7. The E1\widehatE4 protein is highly expressed in the upper layers of differentiated cells in CIN but not in SCC (Doorbar, 2005) ; the E2 protein is also expressed in CIN in intermediate and upper epithelial layers, while expression of E7 mainly occurs in lower layers and in the full thickness of the SCC. This pattern of expression thus links E1\widehatE4 and E2 to cellular differentiation, while in contrast E7 expression occurs in undifferentiated proliferative epidermal cells. However, how transcripts of these different viral proteins are expressed and regulated in vivo has not been resolved. In this study we present a comprehensive description of HPV transcriptomes using RNASeq analyses of HPV16-associated patient lesions and a HPV6b-associated condyloma.
Results and discussion
Comparison of transcript maps from HPV16-associated cervical lesions with published in vitro HPV16 transcript maps RNA was extracted from $ 20 fresh biopsies obtained from patients with HPV-associated lesions. Histological grades and HPV genotypes of all samples were determined with three HPV16-associated lesions (one CIN2, one CIN3 and one SCC), and one HPV6b-associated low grade condyloma selected for deep sequencing. Serial sections of the HPV16-associated CIN2 and SCC and HPV6b-condyloma samples used for the deep RNA sequencing were subjected to both IHC to detect viral E2 protein and the p16 ink4 cellular marker (a surrogate marker indicating expression of the viral E7 protein), and in situ hybridization (ISH) for viral DNA detection, as previously described (Xue et al., 2010 (Xue et al., , 2012 (Fig. 1) . These results confirmed our previous observations of E2 protein expression in the intermediate and upper layers of CIN2 but not in SCC, while in contrast p16 ink4 is detected in the 2/3 lower layers of CIN2 and uniformly in SCC samples. HPV DNA detected by ISH showed episomal amplification in the upper layers of CIN2 (uniform labeling of the entire nuclei) and an integrated pattern in the SCC (punctate labeling). These labeling patterns were also remarkably similar in the HPV6b-associated condyloma and HPV16-associated CIN2, especially regarding the concomitant expression of E2 and viral DNA replication, which is shown here in the HPV6-associated condyloma using an HPV16 E2 antibody that cross reacts with HPV6 E2 protein as reported previously (Lai et al., 2013) . The CIN3 lesion sample was not of sufficient size for sectioning.
In the three HPV16-associated lesions, a total of 21 distinct viral transcripts were identified (Figs. 2 and 3, Table 1 ). Thirteen (A-Q, Fig. 2 ) exclusively covered the early region of the HPV16 genome and used the early polyadenylation site $ nt 4215 of the viral genome. These "early transcripts" have been reported previously (Zheng and Baker, 2006) . In addition 8 "late transcripts" were detected, of which 2 were already known (P and Q), and 6 were newly identified here (represented with the prefix "cuff"). Seven of these late transcripts used the polyadenylation site at nt 7321, while the remaining transcript (cuff21) corresponded to an almost full-length covering of the genome with undefined coding capacity (Fig. 3) . The total absolute abundance of all viral transcripts was $1200 FPKM (Fragments Per Kilobase of transcript per Million fragments mapped) in CIN2, $ 120 in CIN3 and $ 800 in SCC (Table 1) . Remarkably, 16 of the 21 transcripts used the strong E1 splice donor at nt 880 (Figs. 2 and 3) .
Comparison of the HPV16 transcriptome in CIN and SCC lesions
Our data confirmed that all HPV16 transcripts are polycistronic, as reported earlier (Zheng and Baker, 2006) . To determine the coding capacity of the 20 defined transcripts, we searched for translation initiation sequences (AUG with Kozak's motif) located at least 18 nt downstream from the 5 0 end of the transcripts. The latter length is considered the minimal size of mRNA 5 0 UTR required for efficient landing of the ribosomal complex, while the average size 5 0 UTR in eukaryotic transcripts is $ 200 nt (Chatterjee and Pal, 2009 ). In addition, and in accordance with the general scanning model of RNA translation in eukaryotic cells, we only considered the 5 0 most proximal AUG with "Kozak motif". The coding capacity of the 20 mRNAs is given in Fig. 2 for the "early transcripts" and in Fig. 3 for the "late transcripts". The relative abundance of transcripts in the three analyzed HPV16-associated lesions is given in the right part of Figs. 2 and 3, with the absolute values presented in Table 1 .
Eight of the 20 HPV16 transcripts were putative mRNAs encoding the E7 protein. The most frequently used transcription start sites (TSSs) map to around nt 97 and nt 670, which have both been previously described. P 97 is the main promoter for transcription of E6 and E7 in HPV16-associated cervical carcinoma cell lines SiHa and Caski (Smotkin and Wettstein, 1986; Smotkin et al., 1989) and in transfected cells (Romanczuk et al., 1990) . The P 670 promoter has also been defined as a differentiation inducible promoter (Grassmann et al., 1996) . The use of upstream start sites such as 4, 10 or 36 (Fig. 3) has also been proposed but while our approach did not focus on precise determination of the start site for every transcript, we did observe that 5-7% of all transcripts started upstream of P 97 in SCC and CIN3 (discussed below). Interestingly, while transcription starting at P 97 is repressed by E2 (Romanczuk et al., 1990; Thierry, 2009 ), initiation at the other promoters, either downstream or upstream, was predicted to be insensitive to E2 repression, being located away from the E2 binding sites.
Remarkably, none of the "late transcripts", defined as transcripts terminating at the "late" polyadenylation site, used the P 97 TSS. Instead, they made use of putative TSSs at upstream or downstream positions (Fig. 3) . These "late transcripts" represented a relatively small fraction of the total viral RNAs and are relatively more represented in the CIN2 lesion ( $10% of the total transcripts) than in CIN3 and SCC ( $ 3-4%) ( Table 1) .
Description of HPV16 transcripts encoding early proteins
E6: None of the late transcripts and only three early transcripts (A, F and K) contained a full length E6 ORF, as all other transcripts were interrupted within E6 at the splice donor located at nt 226 (Fig. 4A ). These transcripts started at TSS 97, which is only 7 nt upstream of the E6 AUG initiation codon and thus is unlikely to be an efficient translation initiation site for E6 protein. Moreover these transcripts were only evident in the SCC and CIN3 samples where they represent only $ 4% of the total transcripts, with transcript A being the most abundant (Fig. 2) . As approximately 7-8% of total viral transcripts began upstream of P 97 , especially visible in the SCC sample (Fig. 4B) , it is therefore possible that the E6 transcripts may also have been initiated upstream of P 97 . In fact there are two major putative upstream putative TSSs, at $ nt 36 or nt 46, that could give rise to transcripts containing leader sequences of $70 nt that would allow efficient translation of E6. The relative scarcity of full length E6 transcripts in HPV-associated genital lesions has been reported before (Bohm et al., 1993; Nilsson et al., 1996) . E7: In sharp contrast to E6, E7 transcripts are highly represented both in terms of absolute number (8) and relative abundance in the three clinical samples ( Table 1) . As expected for the major oncogenic protein, the highest expression of E7 transcripts was observed in CIN3 and SCC, where they accounted for $45% and 56% of all viral transcripts respectively ( Fig. 2 and Table 1 ). Five E7 transcripts started at P 97 and terminated at the "early" polyA site, with transcript B being the most prominent (44% in SCC) (Fig. 2) . These transcripts are predicted to be sensitive to E2 repression, and they appeared to be amplified in CIN3 and SCC where E2 is either not expressed or is expressed but at low levels compared to in CIN2. However, in CIN1 and CIN2, expression of E2 and E7 proteins is normally spatially separated within the epithelium thus making E7 transcription via the use of the P 97 promoter possible (Xue et al., 2010) . Interestingly, three putative E7 transcripts were also found among the late transcripts described in Fig. 3 , although they were less abundant and all contained the downstream ORFs encoding capsid proteins ( Fig. 3 and Table 1 ). When the levels of E6 and E7 transcripts were compared, it was apparent that E7 transcripts are well expressed in all lesions where they are over 10-fold more abundant than E6 transcripts in high grade lesions while E6 transcripts are undetectable (under the threshold) in CIN2 (Table 1) in accordance with the semi-quantitative data obtained by in situ hybridization reported earlier (Nilsson et al., 1996) . E2: We recently described detection of the E2 protein in HPV16-associated clinical samples and found high levels of expression in CIN1 and CIN2 but very low or complete absence of protein expression in CIN3 and SCC despite presence of abundant transcripts containing E2 sequences (analyzed by the nanostring technology) (Xue et al., 2012) . As shown in Figs. 2 and 3, all viral transcripts contained sequences covering the overlapping E2 and E4 ORFs between $ 3400 and 3632, though only eight of these transcripts (F-P) contained a complete E2 ORF. Furthermore, only transcripts J and P possessed the E2 translational initiation codon at the optimal position within the transcripts for efficient translation. While E2 transcripts represented $ 2% of the total viral transcripts in CIN2, they were undetectable in SCC (Table 1 and Fig. 2 ). Interestingly, transcript P, which is initiated at nt 670 and should therefore be insensitive to E2 repression, was the best expressed putative E2 transcript in CIN2 and CIN3, while it was not expressed in SCC. These data reflect the fact that bona fide E2 transcripts are relatively less abundant than the total number of transcripts containing the complete E2 ORF (F-P Fig. 2 ), which themselves are globally more abundant in SCC ($ 8%) than in CIN2 ($ 5%). This reinforces the point that HPV E2 transcription is a poor marker for gene expression and presence of the protein (Xue et al., 2012) .
E1\widehatE4: A total of 6 transcripts (A, B, C and Q, R, S) were spliced between nt 880 in E1 and nt 3358 in front of E4, thus possessing coding capacity for the E1\widehatE4 protein, which is comprised of the first 5 amino-acids of E1 fused to E4 (Zheng and Baker, 2006; Doorbar et al., 1986; Doorbar et al., 2000) . However, in only 3 of these transcripts (Q, R and S), was the E1\widehatE4 AUG in a favorable position to be translated (Figs. 2 and 3) . The E1 \widehatE4 protein is highly expressed specifically in the most differentiated layers of low grade lesions and is used as a marker of productive viral infection (Doorbar, 2005) . Therefore, and as for the E2 mRNAs, the quantitative data showing higher expression of the E1\widehatE4 transcripts in CIN2 compared to CIN3 and SCC is in agreement with the known protein expression pattern ( Fig. 2 and Table 1 ). In the "early" transcripts map, the E1\widehatE4 messenger Q was the most highly expressed transcript in CIN2, representing $ 80% of all transcripts, while its expression was Fig. 1 . Expression of HPV E2 proteins, cellular p16INK4 and viral DNA in the human cervical samples used for RNA deep sequencing analyses. Labeled serial sections of the HPV16-associated CIN2 and SCC lesions alongside the condyloma associated with HPV6b. IHC with the E2 and p16 antibodies (brown color) together with ISH for viral DNA was carried out as previously described (dark blue for HPV DNA replication, brown for integrated viral DNA) (Xue et al., 2010) . No negative control was used for deep seq analyses and staining of negative samples with the E2 antibody, for both HPV16-associated CIN and HPV6-associated condyloma, were reported previously (Xue et al., 2010; Lai et al., 2013) .
$40% less in CIN3, and lower still in SCC (Fig. 2) . Transcript Q was initiated at TSS 670, and so probably not repressed by E2 even though co-expression of E2 and E4 proteins does occur in the same layers of CIN1 and CIN2 lesions.
E5: E5 is a transforming protein whose expression is disrupted during integration of the viral genome, and is therefore thought to be mainly expressed in low grade lesions (Venuti et al., 2011) . The location of the E5 ORF, just before the "early" PolyA signal, with no splicing signal downstream of E4, made its presence obligatory in all transcripts ending up at the "early" PolyA site (Fig. 2) . However, the only messenger in which E5 AUG is the most 5 0 is transcript E, which is spliced between nt 226 in E6 and nt 3356 in front of E4 (Fig. 1) . Interestingly the E5 transcript was expressed at comparable levels in the 3 samples, showing a gradual increase in CIN3 and SCC (Fig. 2 and Table 1 ). Detection of the E5 protein has long been elusive, but a recent report describes its expression in various in vitro cell models of high and low grade lesions (Sahab et al., 2012) . According to these studies, the level of expression of E5 protein does not drop dramatically with progression from LSIL to HSIL (Low to High grade Squamous Intraepithelial Lesion) and can even be found in Caski cells, where HPV16 DNA is integrated downstream of the E5 ORF, in agreement with the transcript quantification reported here.
Transcription of the capsid proteins
Transcripts able to drive expression of the L1 and L2 capsid proteins were terminated at the "late" Poly A site $ nt 7321, which is located $ 200 nt downstream of the termination codon of the L1 ORF (Fig. 3) . Six out of the 8 late transcripts described in Fig. 3 possessed a complete L1 ORF, using a splice donor at nt 3632 after the E4 and the splice acceptor at nt 5638, corresponding exactly to the L1 AUG (Fig. 3) . L1 is expected to be expressed only in low grade CIN, where productive infection occurs and new viral particles are formed. In only two transcripts (cuff16 and cuff127) was the L1 AUG the most 5 0 AUG for translation initiation, and both were expressed at very low levels in CIN2 and CIN3, but not in SCC. The most highly expressed putative L1 transcript (S) was initiated at TSS 670, and could encode both E1\widehatE4 and L1 but with a much more favorable translational efficiency for E1 \widehatE4 than L1 due to better availability of its AUG initiation codon (Fig. 3) . A similar transcript, not using the splice donor after E4, could also code for L2 but was expressed at very low levels and only in CIN2, where again the E1\widehatE4 translation would be more favorable.
A major transcriptional rearrangement occurs before CIN3
The relative distribution of the HPV16 transcripts was quite similar in the CIN3 and SCC lesions: L1-encoding transcripts were barely detectable in these 2 lesions (Fig. 3) , while E7-encoding transcripts constituted around half of all viral transcripts, followed by E1\widehatE4-and E5-encoding transcripts (Fig. 2) . Transcripts were differently represented in the CIN2 lesion where E7-encoding transcripts comprised only $ 5.3% of the total, while in contrast E1\widehatE4 transcripts were preponderantly expressed (Zheng and Baker, 2006) . Early PolyA (pAE) signal is indicated by a black dot and the letters correspond to the original nomenclature of the various transcripts as defined in Zheng and Baker (2006) . The proposed coding capacity of the transcripts is indicated as well as the % of total viral RNA that they represent in each clinical sample (CIN2, CIN3 and SCC).
at 80% (Fig. 2) . This indicated that progression from CIN2 to CIN3 is associated with major qualitative and quantitative rearrangements of HPV16 transcription as illustrated by the comparison of depth read profiles encompassing only the proximal 1000 nt region of HPV16 in the three types of lesions (Fig. 4A) . These comparable quantifications clearly highlight the much lower transcription covering of the E7 area (between $nt 500 and 800) as well as the almost undetectable transcription over the specific E6 area (between nt 226 and 409) in CIN2 when compared to CIN3 and SCC. In addition, it illustrates the conserved use of previously published splice donors and acceptors and TSS in all lesions, as indicated at the top of the read depth profiles (Fig. 4A) . Quantitative distribution of transcripts given by read depth profiles over the full HPV16 sequence obtained in CIN2 and SCC confirmed very different patterns (Fig. 4B) : the E6 and E7 ORFs were more transcribed in SCC, while the strong splicing for E1\widehatE4 was used in both samples. Transcripts in the late region, between $nt 4000 and late polyA at 7158 were only detected in the CIN2 sample (Fig. 4B) .
Further analyses of the transcripts in HPV16 samples confirmed that integration of the HPV16 viral genome had occurred only in the SCC sample, in agreement with the ISH shown in Fig. 1 . However the SCC sample was heterogeneous and only $ 20% of the cells exhibited overt viral genomic integration signal. Nevertheless, sequences of the transcripts in the SCC sample allowed us to determine the integration sites in both the viral and cellular genomes. Two integration sites were found in the viral genome: one at nt 3505 in E2 and a second at nt 3913 in E5. These integration events gave rise to fusion transcripts between the early HPV16 region and cellular genome, as depicted in Fig. 3B , Fig. 3 . (A) Schematic representation of the HPV16 "late transcripts" ending at the late PolyA signal, indicated as a black dot (pAL). All transcripts are newly described and use the previously unidentified putative TSSs indicated by red arrows on the sequence. Distinct splice donor at nt 3632 and acceptor at nt 5538 are used for these transcripts. An almost full length transcript of undefined structure is also shown. The proposed coding capacities of the transcripts are indicated alongside the % of total viral transcripts that each represents in the three HPV16-associated clinical samples (CIN2, CIN3 and SCC). (B) Sequences of the viral-cellular junctions of the transcripts found at the sites of viral sequences integrated in the cellular genome in the SCC sample. which were present in amounts below the threshold used for quantification of the viral transcripts as reported in Table 1 and Figs. 2 and 3.
Minor transcripts
No transcripts coding for E1 were detected in our data set. An E1-encoding transcript has yet to be described for HPV16 and the corresponding transcript in HPV18, grown in vitro in raft cultures, has only recently been identified (Wang et al., 2011) . This HPV18 transcript is spliced in E6 and is among the rare transcripts ending at the early Poly A that are not spliced out at nt 880 in the E1 ORF (Wang et al., 2011) . The absence of E1 transcript is particularly puzzling in the case of the CIN2 lesion where viral DNA replication commonly occurs (Fig. 1) . Since E1 is a helicase required, together with E2, for viral genome amplification we would also expect the E1 protein to be present in comparable amounts to the E2 protein and its transcripts. Global depth read coverage of the transcripts indicated that there is indeed detectable transcription over the E1 region (between nt 880 and 2614) above background (Fig. 4B) . Moreover, and as expected for an ORF required for viral replication, E1 transcription was higher in the CIN2 biopsy than in the SCC (Fig. 4B) . In addition this level of transcripts was comparable to that seen over the 5 0 part of the E2 ORF (before the highly transcribed E4, between nt 2756 and 3356) (Fig. 4B) . We therefore favor the interpretation that E1 is significantly expressed in CIN2, but that the informatics tools used in this study to identify individual transcripts, did not permit precise mapping of the HPV16 E1-encoding transcripts. One transcript that was found in the three HPV16 samples (cuff21) at $ 3-4% expression levels could contain different species, including the E1 transcript, but its structure was not well defined. No E1 and E2 transcripts have been previously detected in HPV16-associated lesions of low or high grades (Bohm et al., 1993; Nilsson et al., 1996) .
Mapping of viral transcripts of a HPV6b-associated condyloma and comparison with HPV16-associated CIN2
We used the same deep sequencing method to map the viral transcripts in a HPV6b-associated benign condyloma that expressed the E2 protein and exhibited viral DNA amplification (Fig. 1) . The HPV6b transcripts map was constructed using previously published data including data on the closely-related HPV11 (Baker and Calef, 1996; Chow et al., 1987; Renaud and Cowsert, 1996; Sherman et al., 1992) . As noted in these previous reports, the most abundant transcript was transcript A, encoding the E1\wide-hatE4 protein, followed by transcript M, which we allocated to E5. The E1\widehatE4 protein and transcripts have been detected in abundance in all kinds of low grade HPV-associated lesions (Doorbar, 2005; Bohm et al., 1993; Nilsson et al., 1996; Stoler et al., 1992; Stoler et al., 1989) . Surprisingly, the total amount of viral RNA extracted from this lesion was $ 14-fold greater than from the HPV16-associated CIN2 lesion, which exhibited the highest transcript levels among the HPV16-associated lesions ($ 1200 total transcripts in CIN2 vs 17000 in condyloma) (Table 1 and Fig. 5 ). The second unexpected result was that the main early promoter, around nt 90 in front of E6, did not seem to be highly used as mapping of the 5 0 ends of the transcripts gave rise to continuous flat readings from an upstream start site at $ nt 16 (Fig. 5B) . Transcription initiated at the P 90 promoter has been shown to be repressed by E2 similarly to transcription from the equivalent P 97 in HPV16 in transfected cells (Dong et al., 1994) . In contrast, the P 715 promoter, within E7, is used for transcription of over 90% of the transcripts and is probably not susceptible to repression by (Thierry, 2009) (Fig. 5) .
Using the same translation rules as described above for the HPV16 samples, we found that the prominent transcript (A) codes for E1\widehatE4 and represents $ 75% of the total viral transcripts, and that the second most abundant transcripts (M), coding for E5 represents $ 10% of all transcripts. Interestingly, the two E1 and E2 transcripts were expressed at similarly low abundance of $2% of total and were initiated at a putative TSS that is not sensitive to E2 repression, which allowed co-expression of the two proteins in the same cells that is consistent with their concerted roles in viral DNA replication. The HPV16-associated CIN2 and HPV6-associated condyloma samples used for deep sequencing show quite comparable levels of expression of both p16 and E2 as well as similar HPV DNA replication in the upper most differentiated layers (Fig. 1) . When depth read maps of these samples were compared, transcripts distribution were similar with E1\wide-hatE4 transcripts being the most abundant ( $ 80%) while E7 is expressed at $ 10-fold lower levels (Fig. 5B) . However, in contrast with the HPV16-CIN2 the full-length E1 transcript was found in HPV6b-condyloma, while the level of expression of E2 ( $ 2%) was comparable in both types of lesions (Fig. 5A) . Comparison of the read depth maps of the transcripts in the HPV16-associated CIN2 and SCC aligned with the HPV16 genomic sequence at their original quantitative transcript levels of a total of $ 600 for the CIN2 and $ 1000 for the SCC samples (see Table 1 for exact values). (Baker and Calef, 1996) and description of new transcripts (cuff). (B) Comparison of the HPV6b transcripts quantitative profile with that of HPV16-associated CIN2 where total transcript quantities were equalized for better comparison. The HPV6b-associated condyloma gave rise to a total of $ 17,000 transcripts compared to $ 600 from HPV16-associated CIN2.
Comparing read depth transcripts in HPV6b-condyloma and HPV16-CIN2 clearly showed that in both cases there are transcripts covering the L2-L1 region, although they were surprisingly relatively less expressed in condyloma than in CIN2 (Fig. 5B) . The relative amounts of E6-E7 transcripts were also comparably low, with a slightly different pattern due to alternative splicing in HPV16 E6 but not in HPV6b. A specific E7 transcript initiated at the E6 putative internal TSS $nt 280, as previously described in an HPV11-associated cell line (Smotkin et al., 1989) , was relatively abundant ( $ 6%) compared to the putative E6 transcripts which altogether represented only $1% of the transcripts (Fig. 5A) . In conclusion, all viral genes are transcribed in this HPV6b-associated condyloma, leading to the hypothesis that all viral proteins could be expressed in low risk HPV-associated lesions (Fig. 5 ). It will be interesting to compare viral expression in various layers of the lesions in both CIN and condyloma as well as methylation status of the viral genome which is thought to play a crucial role in transcriptional regulation (Vinokurova and von Knebel Doeberitz, 2011; Kalantari et al., 2014) to better understand differential expression of the viral genes and its relationship with epidermal proliferation and differentiation.
Comparison of HPV and cellular transcript abundance
Both HPV and cellular transcripts were detected by sequencing. The abundance of total transcripts followed a similar distribution pattern in CIN2, CIN3, SCC and HPV6b-associated condyloma ( Supplementary Fig. S1 ). In particular, HPV transcript abundance was much higher than the 95% quantile of the entire transcriptome in all four samples ( Supplementary Fig. S1 ). This observation suggested that HPV transcript expression was not minor compared to cellular transcripts, especially in low grade lesion CIN2 and benign condyloma.
Conclusion
We used deep sequencing to construct a quantitative map of HPV transcripts in three HPV16-associated lesions with increasing histological grades: CIN2, CIN3 and SCC, and one benign lesion associated with low risk HPV6b. Our results show that the HPV16 transcriptome in cervical lesions significantly differs from that proposed by studies in cell lines. Moreover, we uncovered important differences in the transcriptome between the lower grade CIN2, and the higher grade CIN3 and SCC. We identified specific transcripts for the HPV16 early ORFs including E1\widehatE4 and E2 transcripts that were more highly expressed in the CIN2 than in the SCC sample. As expected, transcription of E2 found in CIN2 correlated with relatively lower transcription of E7, while this situation was reversed in CIN3 and SCC where E7 transcripts were amplified by $ 8-10-times compared to CIN2, and the specific E2 transcript was absent in SCC. We further compared the HPV16 transcriptome in the CIN2 lesion with the transcriptome of low risk HPV in an HPV6b-associated condyloma. Comparable preponderant ($ 80%) expression of E1\widehatE4 transcripts initiated at the downstream TSS in E7 (nt 670 in HPV16 and nt 715 in HPV6) was evident, thus representing a hallmark of low grade lesions in both high risk and low risk viruses. Interestingly the main E2 transcript was also initiated at the same downstream putative TSS, although less abundantly than E1\widehatE4. There have been 3 previous reports on RNAseq of HPV lesions. However the first one looked at a single sample containing HPV58, and did not use splice read mapping nor transcript assembly/abundance software (Li et al., 2013) ; the second looked for HPV reads without consideration of specific transcripts (Arron et al., 2011) ; and the third was concerned with viral DNA integration sites in the cellular genome and again not with specific viral transcripts (Khoury et al., 2013) . Thus, this report is the first analysis of the structures and relative quantifications of the viral transcripts in patients' lesions aiming to facilitate interpretation of the regulatory pathways leading to oncogenic progression.
Materials and methods

Ethics statement
The study was approved by institutional review boards of KK Hospital SingHealth (CIRB 2010/517/B). The present study only included adult subjects who provided written informed consent.
Tissue specimens
Patient specimens were obtained from the KK Women's and Children's Hospital (Singapore) and fresh biopsies were immediately treated for RNA extraction or fixed in neutral buffered formalin before embedding in paraffin for histology. Diagnosis of specimens was validated by 2 pathologists according to the classification criteria of World Health Organization.
Immunohistochemistry
Consecutive sections of paraffin-embedded tissue samples were labeled with purified anti-HPV16E2C (1/50) and anti-p16 INK4 (clone JC8, Santa Cruz) (1/100) antibodies as previously described (Xue et al., 2010 (Xue et al., , 2012 . in situ hybridizations (ISH) were performed with broad spectrum HPV biotinylated DNA probe sets able to detect 11 types of anogenital HPV ( 
DNA extraction and HPV genotyping
DNA extraction was carried out using a column-based protocol with QIAamp DNA FFPE Tissue Kit (QIAGEN, Germany), according to the manufacturer's instructions. Genotyping was performed using the commercial HPV GenoArray test kit (Hybribio Limited, Hong Kong).
Preparation of RNA samples for sequencing
Total RNA was extracted using the Ambion mirVana miRNA Isolation Kit. The integrity of total RNA was assessed by Agilent Bioanalyzer; only samples with RIN Z7.6 were selected for the analysis. cDNA libraries were generated with 300 ng of total RNA and 2 ml of a 3:1000 dilution of ERCC RNA Spike in Controls (Ambion). The Illumina TruSeq ™ RNA sample preparation kit version 2 was used according to the manufacturer's protocol, with the following modifications: 12 PCR cycles of amplification and the addition of 2 rounds of Agencourt Ampure XP SPRI bead purification (Beckman Courter). The Agilent Bioanalyzer DNA 1000 kit was used to verify the length of the cDNA libraries. The four libraries were sequenced as multiplexes (3 samples/lane) on an Illumina HiSeq2000 using a paired-end run (2 Â 51) and the SBS kit v3.
Data analysis Curation of known transcript annotations
The annotations of known HPV16 and HPV6b transcripts were obtained from in vitro studies (Zheng and Baker, 2006; Baker and Calef, 1996) . However, initial analysis suggested these datasets may be incomplete, so we carried out manual curation of the annotations by searching for reads spanning the splice junctions and examining the donor-acceptor site sequences. We curated the known transcription map of HPV11. We inspected all the known splice sites of HPV11 and discovered that our HPV6b sequencing data did not have read support for any of these splice sites: 1272-3325 (transcript F), 1272-3377 (transcript H), and 3593-5771 (transcript J). In addition, these loci of HPV6b did not have the donor (GU) and accepter (AG) sequences expected of a splice site. In contrast, our HPV6b data had reads spanning 1278-3325, 1278-3377 and 3596-5789 splice junctions, which do contain the canonical GU donor site and AG acceptor site. Therefore, we changed the 1272-3325 junction to 1278-3325 for transcript F; the 1272-3377 junction to 1278-3377 for transcript H; and the 3593-5771 junction to 3596-5789 for transcript J. The curated annotations of known HPV16 and HPV6b transcripts are given in Supplementary Tables S1 and S2.
Mapping and transcript assembly
Quality check (QC) of raw reads was performed using FASTQC and all libraries passed. A hybrid reference genome, named hg19HPV, was built by combining hg19 and genome sequences of 28 HPV subtypes (Supplementary Table S3 ) downloaded from NCBI. Similarly, a hybrid gtf file containing annotations of known gene models and transcripts was generated by combining UCSC known human genes and the above curated HPV transcripts. Raw reads were mapped to hg19 HPV using Tophat (Trapnell et al., 2009) . Tophat alignment was run allowing novel junction discovery and guided by the annotations of known gene models and transcripts. With the aligned reads, we estimated the relative abundance of transcripts using Cufflinks (Trapnell et al., 2010) In RNA-Seq, the relative expression of a transcript is proportional to the count of cDNA fragments that originate from it. These counts must be normalized to the length of the transcripts and the sequencing depth of a sample. FPKM provides such normalized count of fragments. Coding potential of the transcripts was predicted by six-frame translation. Read depth graphs were generated with Integrated Genome Browser (Nicol et al., 2009) to visualize the number of reads covering each nucleotide position.
HPV16
Transcripts of HPV16 were first assembled using Cufflinks guided by the curated transcription map (Zheng and Baker, 2006) for CIN2, CIN3 and SCC independently. Novel transcripts assembled from CIN2, CIN3 and SCC were then merged using Cuffmerge guided by known transcripts. The merged transcripts comprised of both known and novel transcripts were used as guide to re-run Cufflinks with novel transcript discovery disabled. The results from the re-assembling comprise our final transcript map of HPV16.
HPV6b
The transcription map of HPV6b is currently unknown. However, both HPV6b and HPV11 are low-risk viruses and nearestneighbours on the HPV phylogenetic tree (Bernard et al., 2010) . We thus assumed that the transcript map of HPV6b was similar to the known transcript map of HPV11 and used the transcription map of HPV11 to guide the analysis of HPV6b. Novel junctions and isoforms were allowed when running Tophat and cufflinks.
Detection of viral-cellular fusion transcripts
Given that we had paired-end data, we analyzed the reads for the presence of read-pairs where one read aligns to human genome and another to a viral sequence, as this would be an indication of viral-cellular fusion transcripts. We detected 152 such read-pairs in the SCC sample by mapping against the hg19HPV hybrid reference genome using Bowtie2 (Langmead and Salzberg, 2012) . To further define the viral-cellular fusion point to base-pair resolution, we used FusionMap (Ge et al., 2011) to align reads spanning the fusion junctions.
